• Wednesday, Mar 03, 2021
  • Last Update : 09:26 pm

Govt forms divisional committee to assess adverse impact of vaccine

  • Published at 01:34 pm January 19th, 2021
covid-19 coronavirus vaccine
Representational Photo BIGSTOCK

Earlier, the DGDA formulated a guideline on the adverse effects of the Covid-19 vaccine and it was approved by the Health Ministry

The government has formed a divisional level committee to assess adverse events following immunization (AEFI) after the roll out of Covid-19 vaccine in the country.

The Divisional AEFI Causality Assessment Committee includes 14 members, said a letter sent by the Directorate General of Drug Administration (DGDA) to the Directorate General of Health Services (DGHS) on Monday.

The director of the government medical college and hospital will be the committee chairperson at the divisional headquarters and divisional director (health) of DGHS will act as its co-chairperson, it said.


Also Read - Government to fix private vaccine price


Earlier, the DGDA formulated a guideline on the adverse effects of the Covid-19 vaccine and it was approved by the Health Ministry.

In December, the government formed a 15-member committee to assure quality of Covid-19 vaccine. 

The health authorities said a nationwide vaccination program would start from the first week of February.

On Monday, Health Minister Zahid Maleque said Serum Institute of India (SII) was expected to export its first lot of the Oxford-AstraZeneca coronavirus vaccine to Bangladesh by January 25-26.

56
Facebook 55
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail